29 related articles for article (PubMed ID: 30102196)
1. Association of body mass index with clinical outcome of primary WHO grade 4 glioma.
Wang J; Hao Z; Li R; Wu W; Huang N; Zhang K; Hao S; Feng J; Chu J; Ji N
Front Oncol; 2024; 14():1318785. PubMed ID: 38741777
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Syndrome and Survival in Glioblastoma Patients: Retrospective Cohort Study and Review of the Literature.
Lucas D; Carvalho B; Tuna R; Linhares P
Cureus; 2024 Feb; 16(2):e53641. PubMed ID: 38449965
[TBL] [Abstract][Full Text] [Related]
4. Leptin: A Heavyweight Player in Obesity-Related Cancers.
Caruso A; Gelsomino L; Panza S; Accattatis FM; Naimo GD; Barone I; Giordano C; Catalano S; Andò S
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509120
[TBL] [Abstract][Full Text] [Related]
5. GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide.
Parik S; Fernández-García J; Lodi F; De Vlaminck K; Derweduwe M; De Vleeschouwer S; Sciot R; Geens W; Weng L; Bosisio FM; Bergers G; Duerinck J; De Smet F; Lambrechts D; Van Ginderachter JA; Fendt SM
Front Oncol; 2022; 12():988872. PubMed ID: 36338708
[TBL] [Abstract][Full Text] [Related]
6. Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein.
Spiegelberg D; Malmberg C; Tiblom Ehrsson Y; Laurell G
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291945
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
Weller J; Schäfer N; Schaub C; Potthoff AL; Steinbach JP; Schlegel U; Sabel M; Hau P; Seidel C; Krex D; Goldbrunner R; Pietsch T; Tzaridis T; Zeyen T; Borger V; Güresir E; Vatter H; Herrlinger U; Schneider M
J Neurooncol; 2022 Aug; 159(1):95-101. PubMed ID: 35704157
[TBL] [Abstract][Full Text] [Related]
8. Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.
Klement RJ; Popp I; Kaul D; Ehret F; Grosu AL; Polat B; Sweeney RA; Lewitzki V
J Neurooncol; 2022 Jan; 156(2):407-417. PubMed ID: 34940951
[TBL] [Abstract][Full Text] [Related]
9. Associations of General and Abdominal Obesity with the Risk of Glioma Development.
Ahn S; Han K; Lee JE; Jeun SS; Park YM; Yang SH
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201103
[TBL] [Abstract][Full Text] [Related]
10. Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.
Petrelli F; Cortellini A; Indini A; Tomasello G; Ghidini M; Nigro O; Salati M; Dottorini L; Iaculli A; Varricchio A; Rampulla V; Barni S; Cabiddu M; Bossi A; Ghidini A; Zaniboni A
JAMA Netw Open; 2021 Mar; 4(3):e213520. PubMed ID: 33779745
[TBL] [Abstract][Full Text] [Related]
11. Impact of Body Mass Index on Survival Outcome in Patients with Newly Diagnosed Glioblastoma: A Retrospective Single-Center Study.
Cha JY; Park JS; Hong YK; Jeun SS; Ahn S
Integr Cancer Ther; 2021; 20():1534735421991233. PubMed ID: 33543653
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Anthropometric Factors in Glioblastoma Multiforme-Literature Review.
Simińska D; Korbecki J; Kojder K; Kapczuk P; Fabiańska M; Gutowska I; Machoy-Mokrzyńska A; Chlubek D; Baranowska-Bosiacka I
Brain Sci; 2021 Jan; 11(1):. PubMed ID: 33467126
[TBL] [Abstract][Full Text] [Related]
13. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract][Full Text] [Related]
14. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
[TBL] [Abstract][Full Text] [Related]
15. Body Mass Index as a Prognostic Marker in Glioblastoma Multiforme: A Clinical Outcome.
Potharaju M; Mangaleswaran B; Mathavan A; John R; Thamburaj V; Ghosh S; Ganesh S; Kalvakonda C; Loganathan M; Bapu S; Devi R; Verma RS
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):204-209. PubMed ID: 30102196
[TBL] [Abstract][Full Text] [Related]
16. Body mass index as an independent prognostic factor in glioblastoma.
Valente Aguiar P; Carvalho B; Vaz R; Linhares P
Cancer Causes Control; 2021 Apr; 32(4):327-336. PubMed ID: 33447892
[TBL] [Abstract][Full Text] [Related]
17. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
